<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02670304</url>
  </required_header>
  <id_info>
    <org_study_id>28843020</org_study_id>
    <nct_id>NCT02670304</nct_id>
  </id_info>
  <brief_title>Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS</brief_title>
  <official_title>The Randomized Controlled Trial Study of Letrozole in the Prevention of Medium and Severe Ovarian Hyperstimulation Syndrome in Invitro Fertilization Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Letrozole is one kind of aromatase inhibitors which may have effect on decrease estrogen in
      luteal phase and inhibit the luteal function of ovary. In 2009, Letrozole was reported as one
      candidate for the treatment or prevention of ovarian hyperstimulation syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Letrozole was proved to be effective in decreasing the estradiol level of luteal phase after
      ovum picked up. In this randomized controlled study, investigators try to observe the
      effectiveness of letrozole on decreasing the incidence of early ovarian hyperstimulation
      syndrome and vascular epithelium growth factor level of women with high ovarian
      hyperstimulation syndrome risks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of early OHSS</measure>
    <time_frame>up to 1 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>vascular endothelial growth factor level</measure>
    <time_frame>up to 1 months</time_frame>
    <description>vascular endothelial growth factor in pg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hydrothorax</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of liver dysfunction</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of renal dysfunction</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of electrolytic imbalance</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hemoconcentration</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of elevated WBC</measure>
    <time_frame>up to 1 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Ovarian Hyperstimulation Syndrome</condition>
  <arm_group>
    <arm_group_label>letrozole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>letrozole for the first day after ovum picked up at least for 5 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>aspirin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>asprin for the first day after ovum picked up at least for 5 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>letrozole</intervention_name>
    <description>letrozole from the day of oocyte retrieval for 5 days</description>
    <arm_group_label>letrozole</arm_group_label>
    <other_name>Femara</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>aspirin from the day of oocyte retrieval for 5 days</description>
    <arm_group_label>aspirin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertile women undergoing IVF treatment with more than 25 oocytes collected.

        Exclusion Criteria:

          -  letrozole contraindications,e.g. severe hepatic and renal dysfunction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>January 28, 2016</last_update_submitted>
  <last_update_submitted_qc>January 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Zhou Canquan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>letrozole</keyword>
  <keyword>ovarian hyperstimulating syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Letrozole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan to make IPD available</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>March 21, 2016</submitted>
    <returned>April 19, 2016</returned>
    <submitted>December 6, 2016</submitted>
    <returned>January 31, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

